146 related articles for article (PubMed ID: 33834956)
1. Induction Immunosuppressive Therapy for Kidney Transplant in Elderly Recipients: A Single-Center Experience.
El-Hag AD; Dao A; Allam SR; Guiteau JJ; Madhrira MM; Reyad AI
Exp Clin Transplant; 2021 Apr; 19(4):297-303. PubMed ID: 33834956
[TBL] [Abstract][Full Text] [Related]
2. Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience.
Lee H; Lee S; Jeon JS; Kwon SH; Noh H; Han DC; Yun S; Song D
Transplant Proc; 2018 Jun; 50(5):1285-1288. PubMed ID: 29880348
[TBL] [Abstract][Full Text] [Related]
3. Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial.
Martinez-Mier G; Moreno-Ley PI; Budar-Fernández LF; Méndez-López MT; Allende-Castellanos CA; Jiménez-López LA; Barrera-Amoros DA; Aguilar-Sandoval E; De la Paz-Román M; Soto-Miranda E; Rivera-Sanchez Y; Martínez-Maldonado M
Transplant Proc; 2021 Apr; 53(3):1005-1009. PubMed ID: 32178925
[TBL] [Abstract][Full Text] [Related]
4. The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.
Knight RJ; Kerman RH; Schoenberg L; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2004 Sep; 78(6):904-10. PubMed ID: 15385812
[TBL] [Abstract][Full Text] [Related]
5. Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
Martinez-Mier G; Soto-Miranda E; Avila-Pardo SF; Budar-Fernandez LF; Mateu-Rivera LJ; Mendez-Lopez MT; Trujillo-Martinez MF; Uscanga-Montesano A; Avila Y Falfan D
Transplant Proc; 2016 Mar; 48(2):600-4. PubMed ID: 27110011
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Thymoglobulin Induction Therapy in Kidney Transplant From Deceased Donor With Mild to Moderate Acute Kidney Injury.
Lee CH; Gwon JG; Jung CW
Transplant Proc; 2019 Oct; 51(8):2611-2614. PubMed ID: 31474447
[TBL] [Abstract][Full Text] [Related]
7. Tailored immunosuppression after kidney transplantation - a single center real-life experience.
Good-Weber M; Roos M; Mueller TF; Rüsi B; Fehr T
BMC Nephrol; 2020 Nov; 21(1):501. PubMed ID: 33228545
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of thymoglobulin and basiliximab in kidney transplant patients at high risk for acute rejection and delayed graft function.
Chen G; Gu J; Qiu J; Wang C; Fei J; Deng S; Li J; Huang G; Fu Q; Chen L
Exp Clin Transplant; 2013 Aug; 11(4):310-4. PubMed ID: 23121641
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Different Induction Regimes on Serial Lymphocyte Subsets in Kidney Transplant Recipients: A Single Tertiary Center Experience.
Jalalonmuhali M; Ng KP; Lee YW; Gan CC; Hing Wong A; Wan Md Adnan WAH; Cheng SF; Chew CC; Ooi SH; Wong CM; Lim SK
Transplant Proc; 2022 Mar; 54(2):299-306. PubMed ID: 35181166
[TBL] [Abstract][Full Text] [Related]
10. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of thymoglobulin versus basiliximab induction therapies in living donor kidney transplant recipients with mild to moderate immunological risk - a retrospective analysis of UNOS database.
Ali H; Mohammed M; Fülöp T; Malik S
Ann Med; 2023 Dec; 55(1):2215536. PubMed ID: 37232582
[TBL] [Abstract][Full Text] [Related]
12. Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons.
Willoughby LM; Schnitzler MA; Brennan DC; Pinsky BW; Dzebisashvili N; Buchanan PM; Neri L; Rocca-Rey LA; Abbott KC; Lentine KL
Transplantation; 2009 May; 87(10):1520-9. PubMed ID: 19461489
[TBL] [Abstract][Full Text] [Related]
13. Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients.
Dedinská I; Graňák K; Vnučák M; Skálová P; Laca Ĺ; Krivuš J; Galajda P; Mokáň M
Transplant Proc; 2019 Dec; 51(10):3259-3264. PubMed ID: 31732198
[TBL] [Abstract][Full Text] [Related]
14. Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients.
Haririan A; Morawski K; Sillix DH; El-Amm JM; Garnick J; West MS; Granger DK; Migdal SD; Gruber SA
Transplantation; 2005 Mar; 79(6):716-21. PubMed ID: 15785379
[TBL] [Abstract][Full Text] [Related]
15. Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience.
Trofe J; Stratta RJ; Egidi MF; Lo A; Gaber LW; Shokouh-Amiri MH; Grewal HP; Honaker M; Hardinger K; Alloway RR; Gaber AO
Clin Transplant; 2002; 16 Suppl 7():34-44. PubMed ID: 12372042
[TBL] [Abstract][Full Text] [Related]
16. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
Thomusch O; Wiesener M; Opgenoorth M; Pascher A; Woitas RP; Witzke O; Jaenigen B; Rentsch M; Wolters H; Rath T; Cingöz T; Benck U; Banas B; Hugo C
Lancet; 2016 Dec; 388(10063):3006-3016. PubMed ID: 27871759
[TBL] [Abstract][Full Text] [Related]
17. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
18. Anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: Long-term outcome.
Kesiraju S; Paritala P; Rao Ch UM; Athmakuri SM; Reddy VS; Sahariah S
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):9-15. PubMed ID: 24434376
[TBL] [Abstract][Full Text] [Related]
19. Depleting Antibody Induction and Kidney Transplant Outcomes: A Paired Kidney Analysis.
Sampaio MS; Chopra B; Sureshkumar KK
Transplantation; 2017 Oct; 101(10):2527-2535. PubMed ID: 28475563
[TBL] [Abstract][Full Text] [Related]
20. Induction with basiliximab plus thymoglobulin is effective and safe in old-for-old renal transplantation: six-month results of a prospective clinical study.
Favi E; Gargiulo A; Spagnoletti G; Salerno MP; Silvestrini N; Valente I; Citterio F
Transplant Proc; 2010 May; 42(4):1114-7. PubMed ID: 20534237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
